Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics

LinksSchließen

Referenz

Zinner N, Tuttle J, Marks L.
Efficacy and tolerability of darifenacin, a muscarinic M3 selective receptor antagonist (M3 SRA), compared with oxybutynin in the treatment of patients with overactive bladder.

World J Urol 2005;
23 (4) 248-252

Bibliographische Angaben herunterladen

Suchen in:

Aufrufen in: